Abstract
A survey involving 81 individuals living in Dafinso and Vallée du Kou no. 4 (near Bobo-Dioulasso), Burkina Faso, was performed in June 1987, August to September 1987, and January 1988, respectively, at the beginning of, during, and after the transmission season of malaria. The clinical longitudinal study during the transmission period allowed us to define three different groups in terms of both age and occurrence of malaria attack (5,000 Plasmodium falciparum per mm3 of blood and axillary fever of greater than 37.7 degrees C) as follows: group 1, persons less than or equal to 15 years old who had at least one malaria attack during the transmission period; group 2, individuals less than or equal to 15 years old who did not have any malaria attacks; and group 3, individuals considered to be protected (adults greater than 15 years old with no malaria attacks). Soluble interleukin-2 receptor (sIL-2R) levels were found to be significantly increased (P less than 0.001) in the first two groups (1,047 +/- 481 U/ml [mean +/- standard deviation]) as compared with the adult group (605 +/- 307 U/ml). Considering all the groups, no significant difference was observed between observation periods. Levels of sIL-2R were inversely correlated (r = -0.39, n = 237, P less than 0.01) with age (range, 4 to 67 years). Negative correlations were also noticed between the levels of sIL-2R and those of antibodies to somatic antigen of P. falciparum (immunoglobulin G [IgG] class [r = -0.33, n = 237, P less than 0.01] and IgM class [r = -0.20, n = 237, P less than 0.05]). IgG antibody levels to somatic antigen were correlated with age, but IgM antibody levels to somatic antigen were not. The possible role played by sIL-2R in effector mechanisms against malaria is discussed.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baudon D., Roux J., Carnevale P., Rey J. L., Meyran M. B., Brandicourt O. Systematic chemotherapy of febrile cases: a substitute strategy for malaria control in rural areas of Africa. Trans R Soc Trop Med Hyg. 1986;80(1):164–164. doi: 10.1016/0035-9203(86)90225-7. [DOI] [PubMed] [Google Scholar]
- COHEN S., McGREGOR I. A., CARRINGTON S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961 Nov 25;192:733–737. doi: 10.1038/192733a0. [DOI] [PubMed] [Google Scholar]
- Cantrell D. A., Smith K. A. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med. 1983 Dec 1;158(6):1895–1911. doi: 10.1084/jem.158.6.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen S. Immunity to malaria. Proc R Soc Lond B Biol Sci. 1979 Jan 15;203(1153):323–345. doi: 10.1098/rspb.1979.0001. [DOI] [PubMed] [Google Scholar]
- Deloron P., Lepers J. P., Coulanges P. Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria. J Clin Microbiol. 1989 Aug;27(8):1887–1889. doi: 10.1128/jcm.27.8.1887-1889.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gazin P., Robert V., Carnevale P. Etude longitudinale des indices paludologiques de deux villages de la région de Bobo Dioulasso (Burkina Faso). Ann Soc Belg Med Trop. 1985;65 (Suppl 2):181–186. [PubMed] [Google Scholar]
- Gazin P., Robert V., Cot M., Simon J., Halna J. M., Darriet F., Legrand D., Carnevale P., Ambroise-Thomas P. Le paludisme dans l'Oudalan, région sahélienne du Burkina Faso. Ann Soc Belg Med Trop. 1988 Sep;68(3):255–264. [PubMed] [Google Scholar]
- Grau G. E., Fajardo L. F., Piguet P. F., Allet B., Lambert P. H., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 1987 Sep 4;237(4819):1210–1212. doi: 10.1126/science.3306918. [DOI] [PubMed] [Google Scholar]
- Ho M., Webster H. K., Green B., Looareesuwan S., Kongchareon S., White N. J. Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol. 1988 Oct 15;141(8):2755–2759. [PubMed] [Google Scholar]
- Ho M., Webster H. K. Immunology of human malaria. A cellular perspective. Parasite Immunol. 1989 Mar;11(2):105–116. doi: 10.1111/j.1365-3024.1989.tb00652.x. [DOI] [PubMed] [Google Scholar]
- Josimovic-Alasevic O., Feldmeier H., Zwingenberger K., Harms G., Hahn H., Shrisuphanunt M., Diamantstein T. Interleukin 2 receptor in patients with localized and systemic parasitic diseases. Clin Exp Immunol. 1988 May;72(2):249–254. [PMC free article] [PubMed] [Google Scholar]
- Kloster B. E., John P. A., Miller L. E., Rubin L. A., Nelson D. L., Blair D. C., Tomar R. H. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopathol. 1987 Dec;45(3):440–446. doi: 10.1016/0090-1229(87)90095-x. [DOI] [PubMed] [Google Scholar]
- Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. doi: 10.1073/pnas.80.14.4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar A., Moreau J. L., Baran D., Thèze J. Evidence for negative regulation of T cell growth by low affinity interleukin 2 receptors. J Immunol. 1987 Mar 1;138(5):1485–1493. [PubMed] [Google Scholar]
- Lambros C., Vanderberg J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979 Jun;65(3):418–420. [PubMed] [Google Scholar]
- Leonard W. J., Depper J. M., Robb R. J., Waldmann T. A., Greene W. C. Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6957–6961. doi: 10.1073/pnas.80.22.6957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loughnan M. S., Nossal G. J. Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains. Nature. 1989 Jul 6;340(6228):76–79. doi: 10.1038/340076a0. [DOI] [PubMed] [Google Scholar]
- Loughnan M. S., Takatsu K., Harada N., Nossal G. J. T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5399–5403. doi: 10.1073/pnas.84.15.5399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976 Sep 10;193(4257):1007–1008. doi: 10.1126/science.181845. [DOI] [PubMed] [Google Scholar]
- Nguyen-Dinh P., Greenberg A. E. Increased levels of released interleukin-2 receptors in Plasmodium falciparum malaria. J Infect Dis. 1988 Dec;158(6):1403–1404. doi: 10.1093/infdis/158.6.1403. [DOI] [PubMed] [Google Scholar]
- Peyron F., Jacob M. C., Boudin C., Picot S., Bensa J. C., Ambroise-Thomas P. Sous-populations lymphocytaires au cours d'un suivi longitudinal en zone d'endémie palustre. Bull Soc Pathol Exot Filiales. 1989;82(4):483–492. [PubMed] [Google Scholar]
- Peyron F., Vuillez J. P., Barbe G., Boudin C., Picot S., Ambroise-Thomas P. Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria. Acta Trop. 1990 Jan;47(1):47–51. doi: 10.1016/0001-706x(90)90006-l. [DOI] [PubMed] [Google Scholar]
- Pizzolo G., Chilosi M., Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Br J Haematol. 1987 Dec;67(4):377–380. doi: 10.1111/j.1365-2141.1987.tb06156.x. [DOI] [PubMed] [Google Scholar]
- Robb R. J., Munck A., Smith K. A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med. 1981 Nov 1;154(5):1455–1474. doi: 10.1084/jem.154.5.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robert V., Gazin P., Boudin C., Molez J. F., Ouedraogo V., Carnevale P. La transmission du paludisme en zone de savane arborée et en zone rizicole des environs de Bobo Dioulasso (Burkina Faso). Ann Soc Belg Med Trop. 1985;65 (Suppl 2):201–214. [PubMed] [Google Scholar]
- Sharon M., Klausner R. D., Cullen B. R., Chizzonite R., Leonard W. J. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science. 1986 Nov 14;234(4778):859–863. doi: 10.1126/science.3095922. [DOI] [PubMed] [Google Scholar]
- Thelu J., Ambroise-Thomas P., Chumpitazi B., Kupka P. Purification and immunochemical study of Plasmodium falciparum exoantigens. J Parasitol. 1985 Oct;71(5):542–546. [PubMed] [Google Scholar]
- Thelu J., Ambroise-Thomas P., Contat M., Kupka P. Antigènes excrétés-sécrétés par Plasmodium falciparum en cultures in vitro. Etude comparée avec les antigènes somatiques et les antigènes figurés. Bull World Health Organ. 1982;60(5):761–766. [PMC free article] [PubMed] [Google Scholar]
- Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
- Troye-Blomberg M., Perlmann P. T cell functions in Plasmodium falciparum and other malarias. Prog Allergy. 1988;41:253–287. doi: 10.1159/000415226. [DOI] [PubMed] [Google Scholar]
- Wagner D. K., Kiwanuka J., Edwards B. K., Rubin L. A., Nelson D. L., Magrath I. T. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol. 1987 Aug;5(8):1262–1274. doi: 10.1200/JCO.1987.5.8.1262. [DOI] [PubMed] [Google Scholar]
- Wang H. M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med. 1987 Oct 1;166(4):1055–1069. doi: 10.1084/jem.166.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weissman A. M., Harford J. B., Svetlik P. B., Leonard W. L., Depper J. M., Waldmann T. A., Greene W. C., Klausner R. D. Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1463–1466. doi: 10.1073/pnas.83.5.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams A. I. Preparation and use of malarial placenta antigen for immunodiffusion studies in a Nigerian population. Trans R Soc Trop Med Hyg. 1973;67(5):621–630. doi: 10.1016/0035-9203(73)90030-8. [DOI] [PubMed] [Google Scholar]